ClinicalTrials.Veeva

Menu

Safety Profile Following Td Vaccination in Indonesian Pregnant Woman

PT Bio Farma logo

PT Bio Farma

Status

Completed

Conditions

Healthy
Pregnant

Study type

Observational

Funder types

Industry
Other

Identifiers

Details and patient eligibility

About

To assess any serious systemic reaction within 30 minutes after Td immunization in pregnant woman

Full description

Any local and systemic reaction after Td immunization in pregnant woman (as a routine immunization program)

Enrollment

200 patients

Sex

Female

Ages

18 to 39 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy Pregnant Woman aged 18-39 years old
  • 27-36 weeks of pregnancy
  • Subject have been informed properly regarding the study and signed the informed consent form
  • Subject will commit to comply with the instructions of the investigator and the schedule of the trial

Exclusion criteria

  • Given simultaneously with other vaccines or with the interval less than 1 month with other vaccination

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems